Plasma EMMPRIN levels in acute myocardial infarction and stable coronary artery disease.

@article{Akku2016PlasmaEL,
  title={Plasma EMMPRIN levels in acute myocardial infarction and stable coronary artery disease.},
  author={Mehmet Necdet Akkuş and Adil Ormam and Sabri Seyis and Çağdaş Baran and Ayşeg{\"u}l G{\"o}r{\"u}r and Mehmet Nail Bilen},
  journal={Clinical and investigative medicine. Medecine clinique et experimentale},
  year={2016},
  volume={39 3},
  pages={E79-87}
}
PURPOSE The purpose of this study was to determine whether the plasma levels of soluble extracellular matrix metalloproteinase inducer (EMMPRIN) differed among the patients with ST-elevation myocardial infarction (STEMI), non-STEMI (NSTEMI) and stable coronary artery disease (CAD) and the healthy controls, and to identify the factors associated with the… CONTINUE READING